DOI 10.1016/j.ijoa.2026.105207
Effect of maternal oxygen supplementation for parturients undergoing elective cesarean delivery by high‑flow nasal oxygen compared with room air on fetal acid-base status: a randomized clinical trial.
Аннотация
BACKGROUND
High-flow nasal oxygen may offer benefits for maternal during cesarean delivery. However, its effects on fetal acid-base status remain understudied. The objective of this study was to determine if high-flow nasal oxygen improves fetal acid-base outcomes compared to room air in patients undergoing elective cesarean delivery under combined spinal-epidural anesthesia.
METHODS
Patients undergoing elective cesarean delivery, gestation age of at least 37 weeks, age between 18 and 45 were eligible. Participants were randomly assigned 1:1 to receive either high-flow nasal oxygen at 40 L/min with 100% oxygen or room air at 2 L/min after epidural catheter placement until delivery. The primary outcome was umbilical artery lactate level. Secondary outcomes included umbilical artery pH, partial pressure of oxygen, partial pressure of carbon dioxide, Apgar scores, and oxidative stress markers.
RESULTS
Between July to December 2023, 112 completed the study protocol. The high-flow nasal oxygen group had significantly lower umbilical artery lactate levels (1.60 [1.30-1.80] mmol/L vs. 1.80 [1.50-2.30] mmol/L; P = 0.003) and higher umbilical artery pH (7.32 [7.30-7.35] vs. 7.31 [7.28-7.33]; P = 0.004). The high-flow nasal oxygen group also showed improved umbilical artery partial pressure of oxygen (17.34 ± 3.73 vs. 15.67 ± 3.36 mmHg; P = 0.022) and lower partial pressure of carbon dioxide (50.10 [46.50-53.10] vs. 52.60 [48.35-56.65] mmHg; P = 0.003). No significant differences were observed in Apgar scores, oxidative stress markers, or other short-term neonatal outcomes between groups.
CONCLUSIONS
High-flow nasal oxygen during elective cesarean delivery under combined spinal epidural anesthesia appears to improve fetal acid-base status and oxygenation without increasing oxidative stress. These findings emphasize that high-flow nasal oxygen does not adversely affect feta acid-base status, supporting its safety profile in low-risk pregnancies. This safety signal provides a rationale for further studies in higher-risk maternal populations.
TRIAL REGISTRATION: This study is registered at ClinicalTrials.gov with the registration ID: NCT05921955.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.